TrialBlood2021

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Thierry Facon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.